Woodline Partners’s CVS Health CVS Stock Holding History

Woodline Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.9M	Sell	193,966 -1,203,336	-86%	-$92.7M	0.05%	432
2025 Q4	$111M	Buy	1,397,302 +695,554	+99%	+$54.8M	0.43%	38
2025 Q3	$52.9M	Sell	701,748 -261,485	-27%	-$17.9M	0.25%	100
2025 Q2	$66.4M	Buy	963,233 +856,715	+804%	+$56.2M	0.35%	58
2025 Q1	$7.22M	Buy	106,518 +51,925	+95%	+$3.11M	0.05%	418
2024 Q4	$2.45M	Buy	+54,593	New	+$3.06M	0.02%	621
2024 Q1	–	Sell	-76,788	Closed	-$6.06M	–	560
2023 Q4	$6.06M	Buy	+76,788	New	+$5.47M	0.07%	292
2022 Q4	–	Sell	-224,414	Closed	-$21.4M	–	774
2022 Q3	$21.4M	Buy	224,414 +122,610	+120%	+$12.1M	0.3%	94
2022 Q2	$9.43M	Buy	+101,804	New	+$9.94M	0.15%	184
2022 Q1	–	Sell	-216,928	Closed	-$22.4M	–	747
2021 Q4	$22.4M	Sell	216,928 -1,358	-0.6%	-$125K	0.32%	77
2021 Q3	$18.5M	Buy	+218,286	New	+$18.3M	0.3%	94
2020 Q4	–	Sell	-61,476	Closed	-$3.59M	–	236
2020 Q3	$3.59M	Buy	+61,476	New	+$3.83M	0.12%	147
2020 Q1	–	Sell	-158,697	Closed	-$11.8M	–	149
2019 Q4	$11.8M	Buy	+158,697	New	+$11.1M	0.48%	66

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Woodline Partners's CVS Position: Q1 2026 in Review

Woodline Partners reduced its CVS Health (CVS) stake by 86% in Q1 2026, selling an estimated $92.7M and leaving 193,966 shares worth $13.9M. The position accounts for 0.05% of the portfolio, ranked #432.

Woodline Partners first reported a position in CVS in Q4 2019 and has held it in 13 quarters since. The position peaked at $111M in Q4 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Woodline Partners held 193,966 shares of CVS Health worth $13.9M as of Q1 2026.
Woodline Partners sold 1,203,336 CVS Health shares in Q1 2026, an estimated $92.7M.
CVS Health made up 0.05% of Woodline Partners's portfolio in Q1 2026, its #432 holding.
Woodline Partners first reported a position in CVS Health in Q4 2019 and has held it in 13 quarters since.
Woodline Partners's CVS Health position peaked at $111M in Q4 2025.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.